Quantcast

Latest Brain tumor Stories

2014-07-02 16:24:28

In this phase two study, 50 percent of glioblastoma patients lived for two years, an encouraging result for one of the most deadly cancers that often kills patients within one year of diagnosis CHICAGO, July 2, 2014 /PRNewswire-USNewswire/ -- Patients newly diagnosed with glioblastoma multiforme (GBM) and treated with an experimental cancer vaccine made from the patient's own tumor in addition to standard of care lived longer compared to those who received standard of care alone,...

2014-07-01 23:05:50

American Brain Tumor Association’s Annual Conference puts a spotlight on integrated care. Chicago, IL (PRWEB) July 01, 2014 Integrative medicine — a combination of both alternative medicine and conventional treatments — may improve quality of life for brain tumor patients. At the American Brain Tumor Association’s annual patient and family conference July 25-26 in Chicago, experts will discuss the use of integrative medicine and how patients and caregivers can talk with their...

2014-06-30 23:05:29

Dr. Yaron Moshel and ANS Discuss How to Recognize the Symptoms of Pituitary Tumors Morristown, NJ (PRWEB) June 30, 2014 Did you know pituitary tumors affect 15-20% of adults, and are caused by an abnormal growth of cells? How would you know you are suffering from one? Joe Lagitch, 71, of Parsippany has never been sick. His wife, Betty, a retired nurse, says she was surprised when her husband started to complain of headaches, but shrugged it off as a simple sinus infection. Two days later,...

2014-06-30 23:04:20

American Brain Tumor Association and American Association of Neuroscience Nurses releases pediatric nursing clinical guidelines for brain tumor patients. Chicago, IL (PRWEB) June 30, 2014 To meet the unique needs of pediatric brain tumor patients, the American Brain Tumor Association (ABTA) and the American Association of Neuroscience Nurses (AANN) created a clinical practice guideline (CPG) that specializes in the treatment of children with brain tumors. An estimated 4,300 children will...

2014-06-30 08:30:17

SAN ANTONIO, June 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the 2014 BIO International presentation by Chairman and CEO, Craig Dionne, PhD from the 2014 BIO International Convention held June 24th in San Diego, California. Dr. Dionne presented interim results from the Phase Ib and ongoing Phase II study for lead drug candidate, G-202. Summary: -- G-202 Data in Hepatocellular (HCC) Patients...

2014-06-27 14:56:01

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) A clinical phase I trial to examine the safety of the vaccine against gliomas based on mutant IDH1 in human patients is planned Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system. "Low-grade gliomas", which grow comparatively slowly, spread in a diffuse manner across the...

2014-06-27 12:26:56

HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal(®)) and Antineoplaston AS2-1 injections (Astugenal(®)), at the 16(th) International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014. Abstracts and presentations are now available to the public in an online supplement...

2014-06-24 16:24:29

G-202 Data in HCC Patients (Phase I and Phase II) Highly Suggestive of Positive Clinical Activity SAN ANTONIO, June 24, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the 2014 BIO International corporate presentation. Chairman and CEO, Craig Dionne, PhD, presented the company overview and clinical trial updates for G-202 at the 2014 BIO International Convention, today, Tuesday, June 24th, at...

2014-06-24 14:00:24

NYU Langone Medical Center / New York University School of Medicine Leading experts from renowned academic centers join in one voice to encourage new perspectives in addressing brain cancer A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding -- and compromising -- the care of patients with cancers that spread to the brain. In a special article published in the July issue of...

2014-06-24 08:31:08

U.S. Phase 2a Clinical Trial in Recurrent Glioblastoma to Initiate in Early 2015 SYDNEY, June 24, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, today announced plans to move forward with a Phase 2a clinical trial in the U.S. using its formulation of EGFR-targeted, EDV(TM) nanocells packaged with doxorubicin for the treatment...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related